This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Flagship Pioneering has raised a $1.1 billion fund to create another batch of biotechs....
During the 2018 outbreak of Ebola, Regeneron quickly developed a promising monoclonal...
As the human race continues to battle the COVID-19 pandemic, scientists have found...
Credit: Pixabay Toxoplasmosis is a parasitic disease caused by the Toxoplasma gondii...
New web app offers user-friendly data visualization and maps of cases and testing...
Revealing both sides of the story in a single experiment has been a grand scientific...
Two years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying...
Researchers have found a marine snail from the subclass Neomphaliones in a collection...
Two German biotech companies who are at the start of a race to create new vaccines...